Irish biotech firm wins €3m in bid to push diabetes breakthrough over line

Patented peptide which normalises blood sugars now mobilised in race against global epidemic

28th October, 2016
Dr Nora Khaldi and Emmet Browne of Nuritas

Biotech and R&D company Nuritas has secured funding to push ahead with an ingredient that potentially halts the inexorable slide into diabetes of pre-diabetic patients.

The scientifically validated and patent-filed peptide represents a major breakthrough in the battle to prevent type two diabetes.

The revolutionary ingredient is sourced from nature and will stand alone as...

Subscribe from just €1 for the first month!


What's Included

With any subscription you will have access to

  • 971569B3-2C5E-4C45-B798-CEADE16987A8

    Unlimited multi-device access to our iPad, iPhone and Android Apps

  • 099C8662-C57C-42F2-9426-F2F90DF17C8F

    Unlimited access to our eReader library

  • 198AE43B-B9CF-4892-8769-D63C2104BA08

    Exclusive daily insight and opinion seven days a week

  • D8F37B78-25E4-4E4A-A376-4F5789B1564A

    Create alerts to never miss a subject that matters to you

  • B15F2521-37CD-4E02-B898-730A20D39F7F

    Get access to exclusive offers for subscribers on gifts and experiences

  • A564FE02-1AB8-4579-AF9D-BA32A2E5ACA7

    Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine

Share this post

Related Stories

Anton Savage: If it doesn’t fit, get out the drillbit

Columnists Anton Savage 2 hours ago

Aidan Regan: Fiscal deficit is not a concern, but we must widen the tax base

Economics Aidan Regan 2 hours ago

Elaine Byrne: FG’s knives come out behind a veil of gentlemanly conduct

Politics Elaine Byrne 2 hours ago

John Walsh: Going electric comes with potential pitfalls as well as benefits

Transport John Walsh 2 hours ago